Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis is a research paper published in Nature Communications (2024). On theSindex it has a DataRank of 0.823. It has been cited 29 times, with 25 citing works in its 1-hop citation network.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.510
From this paper's citation signal
Citation Network Contribution
0.313
From 18 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 25 citers.
American Heart Association
Grant: EIA34770065
American Heart Association
Grant: 18TPA34230113
Foundation for the National Institutes of Health
Grant: R35 HL144475
NIGMS NIH HHS
Grant: T32 GM145449
NCI NIH HHS
Grant: R01 CA244491
National Institutes of Health
Grant: 5R35HL144475-03
Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis
National Institutes of Health
Grant: 5R01CA244491-02
Macrophage-specific nanotherapy for breast cancer
Greathouse Family Foundation
Falk Foundation
Sarnoff Cardiovascular Research Foundation
Perkin-Elmer Post-doctoral Fellowship
FWCI
4.79
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals